Dr. Reddys Labs (NYSE: RDY) reported Q2 EPS of $0.20, $0.01 worse than the analyst estimate of $0.21. Revenue for the quarter came in at $997 million versus the consensus estimate of $1.02 billion.

For earnings history and earnings-related data on Dr. Reddys Labs (RDY) click here.